CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2–specific T lymphocytes but do not lead to a protective tumor-specific memory response

By Sfondrini Lucia   Besusso Dario   Bronte Vincenzo   Macino Beatrice   Rossini Anna   Colombo Mario   Ménard Sylvie   Balsari Andrea  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 697-704

Springer Publishing Company

Access to resources Recommend Favorite

Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure–activity relationship

By Katayama Kazuhiro   Masuyama Kazuto   Yoshioka Sho   Hasegawa Hitomi   Mitsuhashi Junko   Sugimoto Yoshikazu  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 789-797

Springer Publishing Company

Access to resources Recommend Favorite

Tyrosinase Activated Melanoma Prodrugs

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 7, 2009-09 ,pp. : 717-727

Bentham Science Publishers

Access to resources Recommend Favorite

ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma

By Jin Yao   Bin Zhang   Qiang Huang   Liang Chu   Hua Chen   Jun Dong   Dong Wang   Qing Lan  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1369-1376

Springer Publishing Company

Access to resources Recommend Favorite

Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein

By  

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 28-42

Bentham Science Publishers

Access to resources Recommend Favorite